RYH

Guggenheim S&P 500® Equal Weight Health Care ETF
NAV $126.39
Change $0.09 | 0.07%
As Of 7/28/14

Investment Objectives

Seeks to replicate as closely as possible, before fees and expenses, the performance of the S&P 500 Equal Weight Index Health Care.


Net Asset Value

Net Asset Value $126.39
Change $0.09 | 0.07%


Summary


Ticker RYH
CUSIP 78355W841
Asset Class Sector
Inception Date 11/1/06
Gross Expense Ratio 0.40%
IOPV Ticker RYH.IV
Related Index Ticker S35
Investment Adviser Security Investors, LLC.
Distributor Guggenheim Funds Distributors, LLC.


Profile

Volume 3,999
Last Sale Price $126.40
52-Week Range $126.69 / $96.60
Shares Outstanding 1,800,000
Total Net Assets $227,505,398.00

Overall Morningstar RatingTM *

as of 3/31/14

Among Health Funds

The Fund was rated, based on its risk-adjusted returns, 3 stars for 3 years, 4 stars for 5 years, and 4 stars Overall out of 19, 17 and 19 Health funds, respectively.

Market Close

Market Price $126.40
Premium / Discount $0.01
Change $0.12 | 0.10%
High / Low $126.64 / $125.80


Historical Market Closes to NAV

  Days % of Total Days
Premium 946 48.64%
Discount 893 45.91%
Equal to NAV 106 5.45%
Total 1,945 100%


Characteristics

Number of Stocks 53
Return on Equity (quarterly 6/30/14) 15.15%
Price to Earning (P/E) 24.98
Price to Book (P/B) 3.45
Dividend Amount $0.17
Ex-Dividend Date N/A

Risk

As of 6/30/14
Standard Deviation Sharpe Ratio Beta R-Squared
12.60 1.60 1.02 99.53

Risk Definitions

Standard Deviation A statistical measure of the historical volatility of an investment, computed using 36 monthly returns. More generally, a measure of the extent to which numbers are spread around their average. The higher the number, the more volatility is to be expected.
Sharpe Ratio A risk-adjusted measure developed by William F. Sharpe, calculated using standard deviation and excess return to determine reward per unit of risk. The higher the Sharpe ratio, the better the fund's risk-adjusted performance.
Beta Beta is a statistical measure of volatility relative to the overall market, usually the S&P 500. A positive beta indicates movement in the same direction as the market, while a negative beta indicates movement inverse to the market. Beta for the market is generally considered to be 1. A beta above 1 or below -1 indicates more volatility than the market. A beta between 1 to -1 indicates less volatility than the market.
R-Squared
A measurement of how closely an investment's performance correlates with the performance of a benchmark, such as the S&P 500, and thus a measurement of what portion of its performance may be explained by the performance of the overall market or index. Values for R-squared range from 0 to 100, where 0 indicates no correlation and 100 indicates perfect correlation.

Overview

as of 7/28/2014
Total Assets $227,505,398
Number of Stocks 53
Percent Stock 99.89%
Percent Cash / Other 0.11%

Sectors / Industries

as of 7/28/14

Holdings

as of 7/28/14

Security Name Ticker Shares
Held
Market
Value
% of Net Assets Sector / Industry
VERTEX PHARMACEUTICALS VRTX 55,619 $5,314,951.64 2.34% Biotechnology
COVIDIEN PLC COV 56,744 $4,942,402.40 2.17% Health Care Equipment & Supplies
INTUITIVE SURGICAL, INC. ISRG 10,299 $4,792,021.71 2.11% Health Care Equipment & Supplies
TENET HEALTHCARE CORP THC 87,028 $4,683,846.96 2.06% Health Care Providers & Services
GILEAD SCIENCES, INC. GILD 50,640 $4,631,534.40 2.04% Biotechnology
C.R. BARD, INC. BCR 29,737 $4,553,626.81 2.00% Health Care Equipment & Supplies
PERRIGO COMPANY PRGO 29,118 $4,479,513.12 1.97% Pharmaceuticals
CELGENE CORPORATION CELG 51,111 $4,479,368.04 1.97% Biotechnology
BIOGEN IDEC, INC. BIIB 13,186 $4,435,638.54 1.95% Biotechnology
EDWARDS LIFESCIENCES CORP EW 52,159 $4,428,299.10 1.95% Health Care Equipment & Supplies
UNITEDHEALTH GROUP INC. UNH 51,622 $4,426,586.50 1.95% Health Care Providers & Services
WELLPOINT, INC. WLP 38,252 $4,420,783.64 1.94% Health Care Providers & Services
ABBOTT LABORATORIES ABT 102,718 $4,409,683.74 1.94% Health Care Equipment & Supplies
AMERISOURCEBERGEN CORP ABC 56,946 $4,407,620.40 1.94% Health Care Providers & Services
CERNER CORPORATION CERN 77,200 $4,403,488.00 1.94% Health Care Technology
ELI LILLY & COMPANY LLY 69,397 $4,399,075.83 1.93% Pharmaceuticals
CARDINAL HEALTH, INC. CAH 60,326 $4,376,048.04 1.92% Health Care Providers & Services
CIGNA CORPORATION CI 44,908 $4,350,237.96 1.91% Health Care Providers & Services
BRISTOL MYERS SQUIBB CO BMY 86,804 $4,322,839.20 1.90% Pharmaceuticals
AMGEN INC. AMGN 35,223 $4,320,100.95 1.90% Biotechnology
CAREFUSION CORP CFN 95,673 $4,306,241.73 1.89% Health Care Equipment & Supplies
ALLERGAN INC AGN 25,269 $4,299,520.35 1.89% Pharmaceuticals
HUMANA, INC. HUM 32,785 $4,292,540.05 1.89% Health Care Providers & Services
QUEST DIAGNOSTICS, INC. DGX 69,029 $4,287,391.19 1.88% Health Care Providers & Services
MCKESSON CORPORATION MCK 22,382 $4,284,362.44 1.88% Health Care Providers & Services
AETNA INC AET 50,497 $4,283,155.54 1.88% Health Care Providers & Services
BAXTER INTERNATIONAL BAX 55,902 $4,274,825.94 1.88% Health Care Equipment & Supplies
THERMO FISHER SCIENTIFIC TMO 34,299 $4,266,109.62 1.88% Life Sciences Tools & Services
LABORATORY CORP OF AMERIC LH 40,157 $4,245,398.04 1.87% Health Care Providers & Services
MEDTRONIC, INC. MDT 67,330 $4,225,630.80 1.86% Health Care Equipment & Supplies
ACTAVIS PLC ACT 19,554 $4,202,936.76 1.85% Pharmaceuticals
ST. JUDE MEDICAL INC. STJ 62,804 $4,192,795.04 1.84% Health Care Equipment & Supplies
PATTERSON COS INC PDCO 105,583 $4,187,421.78 1.84% Health Care Providers & Services
ZOETIS INC ZTS 127,248 $4,181,369.28 1.84% Pharmaceuticals
PERKINELMER PKI 88,074 $4,172,946.12 1.83% Life Sciences Tools & Services
HOSPIRA INC HSP 80,458 $4,170,942.72 1.83% Pharmaceuticals
PFIZER INC PFE 138,408 $4,166,080.80 1.83% Pharmaceuticals
VARIAN MEDICAL SYSTEMS IN VAR 49,945 $4,160,418.50 1.83% Health Care Equipment & Supplies
DAVITA, INC DVA 57,746 $4,143,275.50 1.82% Health Care Providers & Services
BOSTON SCIENTIFIC CORP BSX 319,329 $4,141,697.13 1.82% Health Care Equipment & Supplies
BECTON DICKINSON & CO BDX 34,752 $4,129,232.64 1.82% Health Care Equipment & Supplies
MYLAN INC. MYL 81,421 $4,114,203.13 1.81% Pharmaceuticals
WATERS CORPORATION WAT 38,969 $4,106,163.53 1.80% Life Sciences Tools & Services
JOHNSON & JOHNSON JNJ 39,870 $4,071,125.70 1.79% Pharmaceuticals
MERCK & COMPANY, INC. MRK 70,176 $4,068,102.72 1.79% Pharmaceuticals
ALEXION PHARMACEUTICALS I ALXN 24,964 $4,062,641.36 1.79% Biotechnology
ABBVIE INC-W/I ABBV 75,460 $4,055,220.40 1.78% Pharmaceuticals
DENTSPLY INTERNATIONAL XRAY 85,513 $4,035,358.47 1.77% Health Care Equipment & Supplies
REGENERON PHARMACEUTICALS REGN 13,351 $4,034,138.16 1.77% Biotechnology
AGILENT TECHNOLOGIES, INC A 69,871 $3,933,038.59 1.73% Life Sciences Tools & Services
STRYKER CORP SYK 48,982 $3,922,968.38 1.72% Health Care Equipment & Supplies
ZIMMER HOLDINGS INC ZMH 38,723 $3,894,372.11 1.71% Health Care Equipment & Supplies
EXPRESS SCRIPTS HLDGS ESRX 57,094 $3,762,494.60 1.65% Health Care Providers & Services
FEDERATED US TREAS CASH RESERVE INSTITUTIONAL 179,135 $179,134.95 0.08% na

Disclosure

Performance displayed represents past performance, which is no guarantee of future results. Investment returns and principal value will fluctuate so that when shares are redeemed, they may be worth more or less than original cost. Total returns reflect the reinvestment of all dividends. Current performance may be lower or higher than the performance data quoted. For up-to-date fund performance, including performance current to the most recent month-end, please visit the ETF performance page. ETFs are subject to third party transaction fees/commissions. Net asset value (NAV) is calculated by subtracting total liabilities from total assets, then dividing by the number of shares outstanding. Market close is the last price at which shares are traded. Fund shares may trade at, above or below NAV. For additional information, see the fund’s prospectus.

Performance results for periods under one year are short-term and may not provide an adequate basis for evaluating the performance potential of the fund over varying market conditions or economic cycles.

Sector funds may not be suitable for all investors. Investing in sector funds is more volatile than investing in broadly diversified funds, as there is a greater risk due to the concentration of the funds' holdings in issuers of similar offerings. Guggenheim Investment Equal Weight ETFs may not be suitable for all investors. Investment returns and principal value will fluctuate so that when shares are redeemed, they may be worth more or less than original cost. Most investors will also incur customary brokerage commissions when buying or selling shares of an ETF. Investments in securities are subject to market risks that may cause their prices to fluctuate over time. Please review a prospectus carefully for more information of the risks associated with each ETF.

Fund data is subject to change on a daily basis.

Composition is subject to change. Information provided is for illustration purposes only and may not reflect current investments by the fund. Referenced companies are not affiliated with Guggenheim Investments and Guggenheim Investments does not sponsor, endorse, sell or promote the referenced companies.

“Standard & Poor’s®”, “S&P®”, “S&P 500®”, “Standard & Poor’s 500”, “500”, “S&P MidCap 400” and “S&P SmallCap 600” are trademarks of Standard & Poor’s, LLC and have been licensed for use by Guggenheim Investments and its affiliates. Citigroup is a trademark of Citigroup Global Markets Inc. and has been licensed for use by Standard & Poor’s. The product is not sponsored, endorsed, sold or promoted by Standard & Poor’s, and neither Standard & Poor’s nor Citigroup Global Markets Inc. makes no representation regarding the advisability of investing in the product.
 

Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objectives, risks, charges, expenses and other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or contact us.

Guggenheim Investments represents the investment management businesses of Guggenheim Partners, LLC ("Guggenheim"), which includes Security Investors, LLC ("SI"), Guggenheim Funds Investment Advisors, LLC, ("GFIA") and Guggenheim Partners Investment Management ("GPIM") the investment advisers to the referenced funds. Securities offered through Guggenheim Funds Distributors, LLC, an affiliate of Guggenheim, SI, GFIA and GPIM.

2014 Guggenheim Investments. All Rights Reserved.
• Not FDIC Insured • No Bank Guarantee • May Lose Value